Trial Profile
Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Bipolar disorders; Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 24 Aug 2018 Status changed from suspended to completed.
- 31 Jul 2017 Status changed from recruiting to suspended.
- 16 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2019, according to to ClinicalTrials.gov record